トランスクリプション中間因子1ガマは,肺炎と線維症を,アルベオラ型2細胞,線維芽細胞,およびマクロファージを通じて予防する
PubMedで要約を見る
まとめ
この要約は機械生成です。トランスクリプション中間因子1ガンマ (TIF1γ) は,肺線維症 (PF) の治療の可能性を示しています. このタンパク質は肺細胞とマクロファージの主要な線維経路を阻害し,線維症を軽減し,臨床前モデルで肺機能を改善します.
科学分野
- 細胞生物学
- 分子生物学
- 肺医学
背景
- 変形成長因子β (TGFβ) 信号伝達は,線維症の主要な原動力である.
- トランスクリプション中間因子1 (TIF1γ) は,TGFβシグナル伝達を阻害し,肝臓における抗線維作用を示している.
- 肺線維症 (PF) は進行する肺疾患で,治療の選択肢は限られている.
研究 の 目的
- 肺線維症 (PF) の治療の可能性を評価する.
- TIF1γがPFの病原化に関与する細胞過程に影響を与えるメカニズムを調査する.
主な方法
- TGFβに暴露されたアルベオラ型2細胞,線維芽細胞,およびマクロファージを用いたインビトロ研究.
- PFのマウスモデルを用いた in vivo 研究
- マウスとPF患者から精密切断された肺スライスを用いたex vivo研究.
主要な成果
- TIF1γは,TGFβ誘発の2型アルベオラ細胞における上皮細胞- 介質細胞の移行を阻害し, in vitroでフィブロブラストの活性化を阻害した.
- TIF1γは活性化マクロファージにおける炎症性サイトカインの分泌を減少させた.
- vivoでは,TIF1γが肺線維症を有意に減らし,PFマウスモデルで肺機能を改善した.
- TIF1γは,マウスとPF患者からの肺スライスにおける上皮細胞,線維芽細胞,およびマクロファージに類似した抑制効果を示した.
結論
- TIF1γは,肺線維症の重要な細胞,アルベオラ型2細胞,線維芽細胞,およびマクロファージを効果的に調節する.
- TIF1γは,PFの臨床前モデルにおいて有意な抗線維作用を示している.
- TIF1γは肺線維症の遺伝子治療の有望な候補である.
関連する概念動画
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
• Inhalation of Irritants: Inhaling irritants, especially cigarette smoke, are primary causes of inflammation in COPD. Other irritants can include...
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...

